
S3-E25.2 – NASH Drug Development In 2022: A Wealth of Data and a Promising NASH Pipeline
The discussion of drugs in development continues, with specific focus on the treasure trove of data Intercept is producing for OCA and why combination therapy will probably be critical element in the long-term treatment strategy for NASH.